Literature DB >> 15499541

Human monkeypox infection: a family cluster in the midwestern United States.

James J Sejvar1, Yalamanchali Chowdary, Mark Schomogyi, James Stevens, Jayesh Patel, Kevin Karem, Marc Fischer, Matthew J Kuehnert, Sherif R Zaki, Christopher D Paddock, Jeannette Guarner, Wun-Ju Shieh, Joanne L Patton, Nikeva Bernard, Yu Li, Victoria A Olson, Richard L Kline, Vladimir N Loparev, D Scott Schmid, Bradley Beard, Russell R Regnery, Inger K Damon.   

Abstract

BACKGROUND: The outbreak of monkeypox in the Midwestern United States during June 2003 marks the first documented human infection in the Western Hemisphere. Consistent with those in outbreaks in Africa, most cases in this outbreak were associated with febrile rash illness. We describe a cluster of monkeypox in a family with a spectrum of clinical illness, including encephalitis, and outline the laboratory confirmation of monkeypox.
METHODS: Standardized patient information was collected by questionnaire and medical chart review; all cases described were laboratory confirmed. Laboratory methods included nucleic acid detection, viral culture, serologic testing, histopathologic evaluation, and immunohistochemical testing.
RESULTS: Of 3 family members with monkeypox, 2 had rash illness only, and 1 required hospitalization for severe encephalitis. The family member with the mildest clinical course had previously received smallpox vaccination. Diagnostic testing by both polymerase chain reaction and culture revealed infectious monkeypox virus in skin lesions of all 3 patients; 2 patients had orthopoxvirus detected by immunohistochemistry in skin lesions. The patient with encephalitis had orthopoxvirus-reactive immunoglobulin M (IgM) in cerebrospinal fluid. All patients had detectable IgM responses to orthopoxvirus antigens.
CONCLUSIONS: These 3 patients illustrate a spectrum of clinical illness with monkeypox despite a common source of exposure; manifestation and severity of illness may be affected by age and prior smallpox vaccination. We report that monkeypox, in addition to causing febrile rash illness, causes severe neurologic infection, and we discuss the use of novel laboratory tests for its diagnosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15499541     DOI: 10.1086/425039

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  44 in total

1.  Traditional smallpox vaccination with reduced risk of inadvertent contact spread by administration of povidone iodine ointment.

Authors:  Erika Hammarlund; Matthew W Lewis; Jon M Hanifin; Eric L Simpson; Nichole E Carlson; Mark K Slifka
Journal:  Vaccine       Date:  2007-11-29       Impact factor: 3.641

Review 2.  Emerging viral infections of the central nervous system: part 2.

Authors:  Kenneth L Tyler
Journal:  Arch Neurol       Date:  2009-09

3.  Primary Human B Cells at Different Differentiation and Maturation Stages Exhibit Distinct Susceptibilities to Vaccinia Virus Binding and Infection.

Authors:  Nicole Shepherd; Jie Lan; Wei Li; Sushmita Rane; Qigui Yu
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

4.  Optimization of peptide-based ELISA for serological diagnostics: a retrospective study of human monkeypox infection.

Authors:  Melissa E Dubois; Erika Hammarlund; Mark K Slifka
Journal:  Vector Borne Zoonotic Dis       Date:  2012-01-04       Impact factor: 2.133

5.  characterization of acute-phase humoral immunity to monkeypox: use of immunoglobulin M enzyme-linked immunosorbent assay for detection of monkeypox infection during the 2003 North American outbreak.

Authors:  Kevin L Karem; Mary Reynolds; Zach Braden; Gin Lou; Nikeva Bernard; Joanne Patton; Inger K Damon
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

6.  Evaluation of monkeypox virus infection of black-tailed prairie dogs (Cynomys ludovicianus) using in vivo bioluminescent imaging.

Authors:  Elizabeth A Falendysz; Angela M Londoño-Navas; Carol U Meteyer; Nicola Pussini; Juan G Lopera; Jorge E Osorio; Tonie E Rocke
Journal:  J Wildl Dis       Date:  2014-04-29       Impact factor: 1.535

7.  Comparison of West African and Congo Basin monkeypox viruses in BALB/c and C57BL/6 mice.

Authors:  Christina L Hutson; Jason A Abel; Darin S Carroll; Victoria A Olson; Zachary H Braden; Christine M Hughes; Michael Dillon; Consuelo Hopkins; Kevin L Karem; Inger K Damon; Jorge E Osorio
Journal:  PLoS One       Date:  2010-01-27       Impact factor: 3.240

8.  Comparison of monkeypox viruses pathogenesis in mice by in vivo imaging.

Authors:  Jorge E Osorio; Keith P Iams; Carol U Meteyer; Tonie E Rocke
Journal:  PLoS One       Date:  2009-08-11       Impact factor: 3.240

9.  Mousepox in the C57BL/6 strain provides an improved model for evaluating anti-poxvirus therapies.

Authors:  Scott Parker; Akbar M Siddiqui; Christina Oberle; Ed Hembrador; Randall Lanier; George Painter; Alice Robertson; R Mark Buller
Journal:  Virology       Date:  2008-12-18       Impact factor: 3.616

10.  Spectrum of infection and risk factors for human monkeypox, United States, 2003.

Authors:  Mary G Reynolds; Whitni B Davidson; Aaron T Curns; Craig S Conover; Gregory Huhn; Jeffrey P Davis; Mark Wegner; Donita R Croft; Alexandra Newman; Nkolika N Obiesie; Gail R Hansen; Patrick L Hays; Pamela Pontones; Brad Beard; Robert Teclaw; James F Howell; Zachary Braden; Robert C Holman; Kevin L Karem; Inger K Damon
Journal:  Emerg Infect Dis       Date:  2007-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.